December 2, 2018

Biotech Stocks To Watch Next Week: $GBT, $MGNX

With the big ASH meeting ongoing, we have more biotech stocks to watch for big news in the week ahead. I'm feeling better about risk-on biotech stocks with the Federal

by Lance Jepsen

Stock Trading

December 2, 2018

Biotech Stock Immune Design Could Soar Next Week

Biotech stock Immune Design (IMDZ) just released the big news we have been waiting for over this weekend's news cycle. Immune Design just announced long-term follow up results from a

by Lance Jepsen

Stocks To Watch

November 14, 2017

What Stocks To Buy In This Slow Growth Economy

In this slow growth environment, you want to focus on companies that can deliver the growth and that don't need the economy to do well.

by Lance Jepsen

IBM stock does 50 percent Fibonacci retracement.

Stocks To Watch

October 27, 2017

IBM Retracement Setup After Earnings and Revenue Beats

International Business Machines Corporation (IBM) stock looks like a good setup after the stock has done a 50% Fibonacci retracement. On Tuesday, October 17, 2017, IBM reported EPS of $3.30 versus

by Lance Jepsen

Stocks To Watch

July 10, 2017

Top Large Cap Growth ETF iShares Core US Growth ETF

The top large cap growth ETF to trade right now is the iShares Core S&P US Growth ETF IUSG. This ETF tracks the S&P 900 Growth Index which measures growing

by Lance Jepsen

Stocks To Watch

June 29, 2017

PRA Health Sciences On Momentum Squeeze

The stock of PRA Health Sciences looks like a compelling entry on a momentum squeeze after the company announced a partnership with Jumo. PRA Health recently announced a partnership with Jumo,

by Lance Jepsen

Stocks To Watch

June 28, 2017

Cerner Corporation Momentum Squeeze On Awesome Revenue Growth

The stock chart of Cerner Corporation shows a momentum squeeze candidate on excellent sales growth and new business from the Carolinas HealthCare System (CHS). Cerner announced on June 21, 2017, that

by Lance Jepsen

Stocks To Watch

May 18, 2017

Centene Gets S&P Rating Upgrade to BB+ from BB

May 18, 2017: S&P raises Centene's rating one notch to BB+ from BB with an outlook rating of stable. "The rating upgrade on Centene reflects the company's continued successful execution

by Lance Jepsen

Stocks To Watch

March 4, 2017

Sell Exact Sciences For a 55% Win!

March 4, 2017: Sell Exact Sciences for a 55% win in 37 days. Congratulations if you were able to make money on the trade and always remember to sell your

by Lance Jepsen

Stock Trading

February 25, 2017

Medical Device Markets To Benefit From Big VA IoT Push

The Department of Veterans Affairs is on the cutting edge of IoT medical devices. This is great news for medical device stocks and more specifically telehealth companies like Koninklijke Philips

by Lance Jepsen

« Older Articles